Tumour Immunomodulation: Mucins in Resistance to Initiation and Maturation of Immune Response Against Tumours

被引:18
作者
AnandKumar, A. [1 ]
Devaraj, H. [1 ]
机构
[1] Univ Madras, Unit Biochem & Glycotechnol, Madras 600025, Tamil Nadu, India
关键词
CYTOTOXIC T-LYMPHOCYTES; GROWTH-FACTOR RECEPTOR; MUC1 PEPTIDE EPITOPES; HUMAN BREAST-CANCER; DENDRITIC CELLS; COLON-CANCER; O-GLYCAN; MONONUCLEAR-CELLS; TRANSGENIC MICE; OVARIAN-CANCER;
D O I
10.1111/sji.12019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Mucins are high molecular weight glycoproteins designed for cellular protection and sensing the external environment. Aberrant glycosylation and altered mucin expression seen in cancers are implicated in mucin-dependent refraction to immunosurveilance and immunosuppressive induction around the tumour. Although mucins provide molecular targets for immune system's tumour recognition, their characteristics dictate that the nature of immune response required for recognition and lyses of mucin-expressing tumours needs to follow predominantly a MHC-unrestricted TCR-mediated effector cell response. Frequent loss of dendritic cells maturation and elimination of reactive lymphocytes altered adhesive and anti-adhesive properties of the mucins, promote tumour survival and escape from the immune response.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 74 条
[1]
Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2 [J].
Agrawal, B ;
Krantz, MJ ;
Reddish, MA ;
Longenecker, BM .
NATURE MEDICINE, 1998, 4 (01) :43-49
[2]
Rapid induction of primary human CD4+ and CD8+ T cell responses against cancer-associated MUC1 peptide epitopes [J].
Agrawal, B ;
Krantz, MJ ;
Reddish, MA ;
Longenecker, BM .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (12) :1907-1916
[3]
A glycopeptide in complex with MHC class I uses the GaINAc residue as an anchor [J].
Apostolopoulos, V ;
Yuriev, E ;
Ramsland, PA ;
Halton, J ;
Osinski, C ;
Li, WJ ;
Plebanski, M ;
Paulsen, H ;
McKenzie, IFC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) :15029-15034
[4]
Apostolopoulos V, 1997, J IMMUNOL, V159, P5211
[5]
APOSTOLOPOULOS V, 1995, J IMMUNOL, V155, P5089
[6]
Neutralization of pH in the Golgi apparatus causes redistribution of glycosyltransferases and changes in the O-glycosylation of mucins [J].
Axelsson, MAB ;
Karlsson, NG ;
Steel, DM ;
Ouwendijk, J ;
Nilsson, T ;
Hansson, GC .
GLYCOBIOLOGY, 2001, 11 (08) :633-644
[7]
Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium [J].
Babu, Subramani Durai ;
Jayanthi, Venkataraman ;
Devaraj, Niranjali ;
Reis, Celso A. ;
Devaraj, Halagowder .
MOLECULAR CANCER, 2006, 5 (1)
[8]
Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia [J].
Baldus, SE ;
Hanisch, FG .
ADVANCES IN CANCER RESEARCH, VOL 79, 2000, 79 :201-248
[9]
SPECIFIC, MAJOR HISTOCOMPATIBILITY COMPLEX - UNRESTRICTED RECOGNITION OF TUMOR-ASSOCIATED MUCINS BY HUMAN CYTO-TOXIC T-CELLS [J].
BARND, DL ;
LAN, MS ;
METZGAR, RS ;
FINN, OJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :7159-7163
[10]
THE CARBOHYDRATE-COMPOSITION OF MUCIN IN COLONIC-CANCER [J].
BOLAND, CR ;
DESHMUKH, GD .
GASTROENTEROLOGY, 1990, 98 (05) :1170-1177